United States Antimony Co. (NYSE:UAMY – Get Free Report) shares rose 19.7% during trading on Monday. The company traded as high as $3.34 and last traded at $3.3750. 3,319,270 shares changed hands during trading, a decline of 67% from the average daily volume of 9,968,312 shares. The stock had previously closed at $2.82.
Analysts Set New Price Targets
UAMY has been the topic of a number of analyst reports. HC Wainwright dropped their price objective on shares of United States Antimony from $11.75 to $9.25 and set a “buy” rating on the stock in a research note on Wednesday, August 12th. Weiss Ratings reiterated a “sell (d-)” rating on shares of United States Antimony in a research note on Monday, September 14th. Finally, Texas Capital raised United States Antimony to a “strong-buy” rating in a research report on Wednesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $10.12.
Get Our Latest Analysis on United States Antimony
United States Antimony Trading Down 7.5%
The firm has a 50-day moving average of $3.89 and a two-hundred day moving average of $7.00.
Insider Activity at United States Antimony
In other United States Antimony news, Director Joseph Carrabba acquired 21,300 shares of United States Antimony stock in a transaction that occurred on Tuesday, September 1st. The stock was acquired at an average price of $4.72 per share, with a total value of $100,536.00. Following the purchase, the director owned 198,401 shares in the company, valued at approximately $936,452.72. This trade represents a 12.03% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Lloyd EVP, Chief Mining Officer, & Director bought 20,000 shares of the firm’s stock in a transaction on Tuesday, September 1st. The shares were bought at an average cost of $4.63 per share, with a total value of $92,600.00. Following the transaction, the executive vice president directly owned 932,881 shares of the company’s stock, valued at approximately $4,319,239.03. This trade represents a 2.19% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 62,700 shares of company stock valued at $298,592. Insiders own 5.50% of the company’s stock.
Institutional Investors Weigh In On United States Antimony
Several large investors have recently made changes to their positions in UAMY. BlackRock Inc. acquired a new stake in United States Antimony in the 2nd quarter valued at about $82,365,000. Bank of America Corp DE bought a new position in shares of United States Antimony in the second quarter valued at $4,208,000. Bank of New York Mellon Corp bought a new stake in United States Antimony in the second quarter valued at approximately $2,871,000. Orchard Capital Management LLC bought a new stake in shares of United States Antimony during the 2nd quarter worth about $2,230,000. Finally, Deutsche Bank AG acquired a new position in shares of United States Antimony in the second quarter valued at about $1,400,000. Institutional investors own 9.49% of the company’s stock.
United States Antimony Company Profile
United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.
Further Reading
- Five stocks we like better than United States Antimony
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
Receive News & Ratings for United States Antimony Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United States Antimony and related companies with MarketBeat.com's FREE daily email newsletter.
